PRN: Elsevier / MC Strategies Introduces Additional Resources to its ICD-10 Roadmap, Helping Healthcare Organizations Prepare for October 2013

09/ago/2011 11.14.49 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Elsevier / MC Strategies Introduces Additional Resources to its ICD-10 Roadmap, Helping Healthcare Organizations Prepare for October 2013

 
[09-August-2011]
 

ATLANTA, Georgia, August 9, 2011 /PRNewswire/ --


"Two Years and Counting" White Paper Helps Users Plan Their Transition Schedule and Identify Critical Milestones and Educational Needs

Elsevier / MC Strategies, a pioneer in providing eLearning solutions to more than 1,300 healthcare organizations, today announced the addition of a white paper, "Two Years and Counting", as well as updates to its eBook, A Guide to Education and Training for ICD-10 Implementation, to its ICD-10 Roadmap.

Elsevier's ICD-10 Roadmap is a comprehensive, phased transition plan that serves as a guide for successful planning and implementation. The roadmap is divided into four phases of the transition - evaluation, planning, action and management - and offers recommendations for planning as well as an educational program that provides the right training at the right time. As noted on the roadmap, organizations should now be performing gap analyses and improving the foundational knowledge of their staff. Elsevier's ICD-10 Readiness Assessment tool, and Mosby's Anatomy & Physiology, Pathophysiology and Medical Terminology Curricula will help ensure that organizations are ready for the next phase.

The newest white paper from Elsevier, "Two Years and Counting," details where healthcare organizations should be in their transition process, and provides an in-depth look at the four phases of transition, including the steps that need to be taken in each phase to ensure a smooth transition.  To further emphasize the need to act, Elsevier has added a Countdown to ICD-10 clock to their icd-10online.com web site.

"As the 2013 implementation date for the ICD-10 draws closer, the transition from ICD-9 is becoming a primary concern for many healthcare organizations," said Deborah Neville, RHIA, CCS-P, PCS, Director of Revenue Cycle, Coding and Compliance, Elsevier/ MC Strategies. "There are numerous benefits to the early adoption of the ICD-10, including improvements in patient outcomes and quality measures reporting, revenue cycle analytics and associated reimbursement, improved data for research, and consistent coding with systems worldwide - all of which can be accomplished with the proper training and support."

In addition to "Two Years and Counting", Elsevier's updated eBook provides educational recommendations with professional requirements and timelines in mind.  As part of Elsevier's commitment to ensuring a smooth transition to ICD-10, additional resources such as ICD-10 webinar recordings and a collection of ICD-10 white papers are available on http://www.ICD-10online.com, along with the eBook.

To stay current with the ICD-10 transition, please find Elsevier ICD-10 on Facebook at http://www.facebook.com/ICD10Online and on Twitter at @ICD10Online. For more information about Elsevier ICD-10 eLearning Solutions, including purchasing information, please visit http://www.ICD-10online.com or call +1 866 429 3067.

About Elsevier Clinical Decision Support

Elsevier Clinical Decision Support (http://www.clinicaldecisionsupport.com), a division of Elsevier, the global leader in medical and health information, provides world class information and point-of-care technology solutions that optimize decisions and actions to improve the overall quality, safety and cost-effectiveness of care. The business delivers on this promise through actionable clinical content, care planning and documentation, drug reference and decision support, learning and performance management, and data mining and outcomes analytics solutions for provider, pharmacy and payer organizations.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care ins! titutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact

Tom Reller
Vice President of Global Relations, Elsevier
+1-212-462-1912
t.Reller@elsevier.com


Company Codes: LSE:REL, NYSE:RUK, NYSE:ENL
blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl